P01.029  Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1)

A. R. Korshoej; S. Lukacova; J. H. Sørensen; F. L. Hansen; N. Mikic; A. Thielscher; S. O. S. Cortnum; T. L. Guldberg; Y. Lassen-Ramshad; C. Rahbek; K. E. Severinsen; G. B. von Oettingen

doi:10.1093/neuonc/noy139.071

P01.029 Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1)

A. R. Korshoej
, S. Lukacova
, J. H. Sørensen
, F. L. Hansen
, N. Mikic
, A. Thielscher
, S. O. S. Cortnum
, T. L. Guldberg
, Y. Lassen-Ramshad
, C. Rahbek
, K. E. Severinsen
, G. B. von Oettingen

Aarhus University Hospital

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	Neuro-Oncology
Volume	20
Issue number	suppl_3
Pages (from-to)	iii234-iii235
Number of pages	2
ISSN	1522-8517
DOIs	https://doi.org/10.1093/neuonc/noy139.071
Publication status	Published - 2018
Event	13th Meeting of the European Association of Neurooncology - Stockholm, Sweden Duration: 10 Oct 2018 → 14 Oct 2018 Conference number: 13

Conference

Conference	13th Meeting of the European Association of Neurooncology
Number	13
Country/Territory	Sweden
City	Stockholm
Period	10/10/2018 → 14/10/2018

Access to Document

10.1093/neuonc/noy139.071

OpenUrl availability

Check availability in DTU Findit

Cite this

Korshoej, A. R., Lukacova, S., Sørensen, J. H., Hansen, F. L., Mikic, N., Thielscher, A., Cortnum, S. O. S., Guldberg, T. L., Lassen-Ramshad, Y., Rahbek, C., Severinsen, K. E., & von Oettingen, G. B. (2018). P01.029 Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1). Neuro-Oncology, 20(suppl_3), iii234-iii235. https://doi.org/10.1093/neuonc/noy139.071

@article{fa02500db81e4c12a9b8de97935a22f8,

title = "P01.029 Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1)",

author = "Korshoej, \{A. R.\} and S. Lukacova and S{\o}rensen, \{J. H.\} and Hansen, \{F. L.\} and N. Mikic and A. Thielscher and Cortnum, \{S. O. S.\} and Guldberg, \{T. L.\} and Y. Lassen-Ramshad and C. Rahbek and Severinsen, \{K. E.\} and \{von Oettingen\}, \{G. B.\}",

year = "2018",

doi = "10.1093/neuonc/noy139.071",

language = "English",

volume = "20",

pages = "iii234--iii235",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "suppl\_3",

note = "13th Meeting of the European Association of Neurooncology ; Conference date: 10-10-2018 Through 14-10-2018",

}

Korshoej, AR, Lukacova, S, Sørensen, JH, Hansen, FL, Mikic, N, Thielscher, A, Cortnum, SOS, Guldberg, TL, Lassen-Ramshad, Y, Rahbek, C, Severinsen, KE & von Oettingen, GB 2018, 'P01.029 Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1)', Neuro-Oncology, vol. 20, no. suppl_3, pp. iii234-iii235. https://doi.org/10.1093/neuonc/noy139.071

P01.029 Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1). / Korshoej, A. R.; Lukacova, S.; Sørensen, J. H. et al.
In: Neuro-Oncology, Vol. 20, No. suppl_3, 2018, p. iii234-iii235.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - P01.029 Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1)

AU - Korshoej, A. R.

AU - Lukacova, S.

AU - Sørensen, J. H.

AU - Hansen, F. L.

AU - Mikic, N.

AU - Thielscher, A.

AU - Cortnum, S. O. S.

AU - Guldberg, T. L.

AU - Lassen-Ramshad, Y.

AU - Rahbek, C.

AU - Severinsen, K. E.

AU - von Oettingen, G. B.

N1 - Conference code: 13

PY - 2018

Y1 - 2018

U2 - 10.1093/neuonc/noy139.071

DO - 10.1093/neuonc/noy139.071

M3 - Conference abstract in journal

SN - 1522-8517

VL - 20

SP - iii234-iii235

JO - Neuro-Oncology

JF - Neuro-Oncology

IS - suppl_3

T2 - 13th Meeting of the European Association of Neurooncology

Y2 - 10 October 2018 through 14 October 2018

ER -

Korshoej AR, Lukacova S, Sørensen JH, Hansen FL, Mikic N, Thielscher A et al. P01.029 Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1). Neuro-Oncology. 2018;20(suppl_3):iii234-iii235. doi: 10.1093/neuonc/noy139.071